A Pilot Study of Pivanex in Patients With Malignant Melanoma

Clinical trial NCT00087477 · TERMINATED

Trial details

NCT number: NCT00087477
Sponsor: Titan Pharmaceuticals
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2004-01-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.